Nexeon MedSystems Inc. (NXNN) Comparison with companies in other sectors?

Nexeon MedSystems Inc. has a share price of 786.25M. You can analyze Nexeon MedSystems Inc. (NXNN) competitors across different market sectors through stock heatmaps.

What are NXNN's NET and operating margins?

Nexeon MedSystems Inc. (NXNN) operating margin is around -1.90, and net profit margin is approximately -0.66 as of the latest reports.

In what way does NXNN's earnings per share (EPS) trend reflect its financial momentum?

Nexeon MedSystems Inc. (NXNN) EPS is -2.78 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Nexeon MedSystems Inc. is -0.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Nexeon MedSystems Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Nexeon MedSystems Inc. like P/E which is -0.00, P/B which is 0.00, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Nexeon MedSystems Inc.

NXNN•PNK

Healthcare

Medical - Devices

$0.00

$0.00(0.00%)

Nexeon MedSystems Inc. (NXNN) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-2.78

P/E Ratio

-0.00

ROE

-0.19%

Net Margin

-0.66%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$78.63K

Shares OutstandingTotal number of shares issued

$786.25M

Book Value/ShareNet worth per share

$6.68

Revenue/ShareAnnual revenue per share

$1.86

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-2.78

Net MarginNet income as percentage of revenue

-65.93%

Operating MarginOperating income as percentage of revenue

-189.69%

ROEReturn on shareholders' equity

-18.78%

ROAReturn on total assets

-10.70%

ROCEReturn on capital employed

-41.17%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.79

Cash/ShareCash and equivalents per share

$0.50

FCF YieldFree cash flow as percentage of market cap

-4037.50%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for NXNNFinancial Ratios Analysis details for NXNN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for NXNNSector Benchmarking details for NXNN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Nexeon MedSystems Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Nexeon MedSystems Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Nexeon MedSystems Inc.'s unique business strengths and challenges.

Key Financial Metrics for Nexeon MedSystems Inc.

For Nexeon MedSystems Inc., essential financial indicators include EPS -2.78, PE -0.00, and ROE -0.19. These key ratios reveal insights into Nexeon MedSystems Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Nexeon MedSystems Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Nexeon MedSystems Inc.

Metrics like Net Margin -65.93% and ROA -10.70% shed light on how well Nexeon MedSystems Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Nexeon MedSystems Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Nexeon MedSystems Inc.

Using ratios such as P/B Ratio 0.00 and PEG Ratio -0.00, investors can assess whether Nexeon MedSystems Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Nexeon MedSystems Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Nexeon MedSystems Inc.

Financial health indicators, such as Debt/Equity Ratio 0.36 and Cash Flow $-1.79, provide a snapshot of Nexeon MedSystems Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Nexeon MedSystems Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Nexeon MedSystems Inc.

Investing in Nexeon MedSystems Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Nexeon MedSystems Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;